Profile data is unavailable for this security.
About the company
Kinarus Therapeutics Holding AG is a Switzerland-based Company that operates as a biopharmaceutical industry engaged in diseases treatment. The Company conducts its work within clinical-stage area and its activities include discovery, examination and development of medicines that are intended for the treatment of viral, respiratory, and ophthalmic diseases. Kinraus therapeutic drug is patent protected KIN001 which is a combination of pamapimod and pioglitazone. KIN0001 offers oral, long-term treatment of diseases with severe impact on the comfort of living.
- Revenue in CHF (TTM)0.00
- Net income in CHF-49.38m
- Incorporated1997
- Employees15.00
- LocationKinarus Therapeutics Holding AGTechnologiepark BaselHochbergerstrasse 60CBASEL 4057SwitzerlandCHE
- Phone+41 616332971
- Fax+41 445000801
- Websitehttp://www.kinarus.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Knafaim Holdings Ltd | 24.33m | 2.61m | 39.71m | 3.65k | 15.20 | 0.7366 | 7.15 | 1.63 | 0.7111 | 0.7111 | 6.62 | 14.67 | 0.1511 | -- | 5.88 | -- | 1.52 | -0.7555 | 2.08 | -1.18 | 38.31 | 34.91 | 10.03 | -27.02 | -- | 1.13 | 0.4746 | 5.66 | -5.07 | -58.24 | 180.33 | -- | -67.51 | -- |
Mesa Air Group Inc | 407.58m | -103.80m | 40.39m | 2.11k | -- | 0.3061 | -- | 0.0991 | -2.99 | -2.99 | 11.72 | 3.76 | 0.5443 | 14.47 | 65.79 | 208,170.20 | -13.86 | -3.15 | -18.46 | -3.93 | 15.12 | 23.62 | -25.47 | -7.54 | 0.3504 | -0.6538 | 0.7178 | -- | -6.20 | -6.08 | 34.25 | -- | -20.85 | -- |
Jet Airways (India) Ltd | 1.11bn | -66.58m | 45.91m | 16.56k | -- | -- | 3.05 | 0.0413 | -75.84 | -75.84 | 1,265.28 | -- | -- | -- | -- | 6,595,767.00 | -- | -5.57 | -- | -59.54 | 42.49 | 32.54 | -5.99 | -3.94 | -- | -0.5532 | -- | -- | 8.01 | 5.40 | -142.47 | -- | 33.80 | -- |
Star Flyer Inc | 243.65m | 13.04m | 56.74m | 702.00 | 4.86 | -- | 3.22 | 0.2329 | 548.54 | 548.54 | 10,979.29 | 743.83 | 1.83 | 58.70 | 28.54 | 58,754,980.00 | 9.83 | -11.17 | 14.25 | -15.66 | 11.34 | -2.31 | 5.36 | -9.51 | 2.16 | -- | 0.6658 | -- | 24.00 | 0.041 | 1,149.32 | 12.20 | -40.43 | -- |
AirAsia Indonesia Tbk PT | 412.94m | -123.63m | 56.96m | 1.89k | -- | -- | -- | 0.1379 | -206.19 | -206.19 | 688.69 | -861.39 | 1.23 | 60.91 | 134.18 | 3,836,675,000.00 | -36.74 | -33.72 | -- | -- | 14.50 | 13.05 | -29.93 | -41.26 | 0.0322 | -1.25 | -- | -- | 75.25 | 9.37 | 34.46 | -- | -46.23 | -- |
Kinarus Therapeutics Holding AG | 0.00 | -49.38m | 64.43m | 15.00 | -- | -- | -- | -- | -169.12 | -169.12 | 0.00 | -1.09 | 0.00 | -- | -- | -- | -697.16 | -483.12 | -821.63 | -658.52 | -- | -- | -- | -397.95 | -- | -241.72 | -- | -- | -- | -- | -42.17 | -- | -- | -- |
Gol Linhas Aereas Inteligentes SA | 2.83bn | -388.60m | 70.70m | 13.69k | -- | -- | -- | 0.025 | -6.00 | -6.00 | 43.78 | -55.23 | 0.9602 | 14.11 | 9.72 | 1,339,962.00 | -13.17 | -21.47 | -301.43 | -99.38 | 32.28 | 20.38 | -13.72 | -25.44 | 0.2817 | 0.7443 | 4.87 | -- | 23.52 | 10.47 | 21.72 | -- | -0.0838 | -- |
AGP Corp | 78.40m | 4.73m | 73.90m | 638.00 | 15.10 | 1.33 | 8.86 | 0.9426 | 61.32 | 61.32 | 1,015.62 | 697.81 | 1.02 | 11.49 | 7.77 | 20,803,290.00 | 6.13 | 2.36 | 6.90 | 2.75 | 19.39 | 14.25 | 6.04 | 2.80 | 3.74 | -- | 0.0623 | 75.41 | 17.64 | -1.23 | 34.96 | -4.72 | -4.29 | 26.30 |
Data as of Sep 20 2024. Currency figures normalised to Kinarus Therapeutics Holding AG's reporting currency: Swiss Franc CHF
Holder | Shares | % Held |
---|---|---|
UBS Asset Management Switzerland AGas of 31 Jul 2024 | 2.29k | 0.05% |
Credit Suisse AGas of 31 Jul 2024 | 179.00 | 0.00% |
Banque Cantonale Vaudoise (Investment Management)as of 31 Mar 2024 | 78.00 | 0.00% |
BlackRock Asset Management Schweiz AGas of 05 Sep 2024 | 33.00 | 0.00% |
Z�rcher Kantonalbank (Investment Management)as of 31 Jul 2024 | 3.00 | 0.00% |
Carne Global Fund Managers (Schweiz) AGas of 31 Jul 2024 | 3.00 | 0.00% |
Pictet Asset Management SAas of 31 May 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 31 Jul 2024Source: FactSet Research Systems Inc.